| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.069 | 0.2 |